Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4) Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Everolimus
  • Kidney Neoplasms

abstract

  • Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma (RECORD-4), ClinicalTrials.gov identifier, NCT01491672.

publication date

  • March 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5006123

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdv612

PubMed ID

  • 26681676

Additional Document Info

start page

  • 441

end page

  • 8

volume

  • 27

number

  • 3